| Mitsie Shurtz, MS, CCC-SLP | |
|
3030 Nw Expwy Ste 809, Oklahoma City, OK 73112-5466 | |
| (405) 917-7160 | |
| Not Available |
| Full Name | Mitsie Shurtz |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 3030 Nw Expwy Ste 809, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003292095 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 3858 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mitsie Shurtz, MS, CCC-SLP 3030 Nw Expwy Ste 809, Oklahoma City, OK 73112-5466 Ph: (405) 917-7160 | Mitsie Shurtz, MS, CCC-SLP 3030 Nw Expwy Ste 809, Oklahoma City, OK 73112-5466 Ph: (405) 917-7160 |
News Archive
An international research collaboration has identified 13 new gene sites associated with the risk of coronary artery disease and validated 10 sites found in previous studies. Several of the novel sites discovered in the study, which is being published online in Nature Genetics, do not appear to relate to known risk factors, suggesting previously unsuspected mechanisms for cardiovascular disease.
A novel potential therapy based on a natural human protein significantly slows muscle damage and improves function in mice who have the same genetic mutation as boys with the most common form of muscular dystrophy, according to a paper published online Dec. 27 in the Proceedings of the National Academy of Sciences.
Colorectal cancer is the fourth leading cause of cancer-related deaths worldwide. In a new study, researchers demonstrate for the first time that a previously uncharacterized protein is increased in colon cancer. The protein is immunoglobulin containing proline rich receptor-1 (IGPR-1) which was recently identified in the same laboratory as a cell adhesion molecule.
Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced a co-operative drug development project with the Fraunhofer Institute for Cell Therapy and Immunology IZI in Leipzig, Germany for the preclinical and clinical development of WF10 as a potential treatment for Allergic Rhinitis.
The Asbestos Disease Awareness Organization, the leading organization serving as the voice of asbestos victims, today applauds Representative Steve Cohen (D-TN - 09) and cosponsors for introducing a resolution that declares the first week of April as "National Asbestos Awareness Week" and seeks to "raise public awareness about the prevalence of asbestos-related diseases and the dangers of asbestos exposure."
› Verified 6 days ago
Ms. Shanun Micaela Gibson, M.S.,CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9031 Sw 29th St, Oklahoma City, OK 73179 Phone: 405-732-3946 Fax: 405-261-6311 | |
Heather Mitchell, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1211 N Shartel Ave, Suite 200, Oklahoma City, OK 73103 Phone: 405-355-3239 | |
Hannah Lopez, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5701 Se 74th St, Oklahoma City, OK 73135 Phone: 405-610-1909 Fax: 405-910-1910 | |
Mrs. Rheagan Diane Ballard, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2828 Nw 57th St Ste 100, Oklahoma City, OK 73112 Phone: 405-286-3749 | |
Leigh Hibbard, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13819 Quail Pointe Dr, Oklahoma City, OK 73134 Phone: 405-467-6782 | |
Priscilla Phillips, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 309 Sw 59th St Ste 305, Oklahoma City, OK 73109 Phone: 405-355-3239 |